Key result
Regional hospital-at-home model linked to high survival and a ~36% decline in 30-day readmissions.
Why the study?
The patient population, care pathways, and short-term safety outcomes of a regional hospital-at-home model, as well as variation by diagnosis and referral source, had not been described.
What are the short-term safety outcomes and care pathways of a regional hospital-at-home model in a clinically diverse patient population?
Observational (n=2,511)
Yes
What are the short-term safety outcomes and care pathways of a regional hospital-at-home model in a clinically diverse patient population?
A regional hospital-at-home model was safely implemented with high 30-day survival and declining readmission rates in a complex, diverse patient population.
Answers are grounded in this paper and cite their sources.
Supports scalable regional hospital-at-home with stable safety metrics in complex patients; leaves open need for controlled trials versus inpatient care.
To describe the patient population, care pathways, and short-term safety outcomes of a regional hospital-at-home model in Region Zealand, Denmark, between 2022 and 2024, and to explore variation in outcomes by diagnosis and referral source. Retrospective observational study using registry-based data and internal monitoring records. A publicly funded, cross-sectoral hospital-at-home service coordinated centrally and delivered via municipal nurses and mobile treatment units. We included 2,511 patients with a median age of 72 years (IQR 60–80). Patients generally presented with substantial comorbidity and represented a broad, clinically diverse population. Length of stay, unplanned hospital contacts during treatment or within 24 h after planned completion, 30-day readmissions, and 30-day survival. The median length of stay increased from 5.1 days in 2022 to 7.3 days in 2024. Rates of unplanned hospital contacts remained stable (27.0–31.1%), whereas 30-day readmission rates declined from 11.0% to 7.0% over the study period. Thirty-day survival remained consistently high (91.6–92.4%). Infectious diseases were the most frequent diagnostic category (43–47%). Outcomes varied by diagnosis and referral source, with longer treatment durations observed among patients with orthopaedic and chronic conditions. Hospital-level care delivered in patients’ homes was implemented on a regional scale with acceptable short-term outcomes across a clinically complex and socially diverse patient population, including individuals living alone. The variation in outcomes across diagnostic groups underscores the importance of flexible, diagnosis-informed care pathways and structured cross-sectoral organisation in hospital-at-home models. Not applicable. This study includes a large, regional cohort of patients receiving hospital-level care at home, capturing real-world implementation across a publicly funded, cross-sectoral healthcare system. The comprehensive linkage of registry data enabled a robust assessment of short-term outcomes, including readmissions, unplanned hospital contacts, and mortality, with minimal loss to follow-up. The study population was clinically complex and socially diverse, including a high proportion of older adults, patients with substantial comorbidity, and individuals living alone. The observational design without a control group limits causal inference and precludes direct comparison with traditional inpatient hospital care. The data did not include patient-reported outcomes or detailed information on in-home clinical processes, which limits insight into patient experience and specific care components.
No takes yet. Share an insight, caveat, or question.
Hägi‐Pedersen et al. (2026) conducted an observational in Clinically diverse conditions requiring hospital-level care (n=2,511). Regional hospital-at-home model was evaluated on Length of stay, unplanned hospital contacts, 30-day readmissions, and 30-day survival. A regional hospital-at-home model demonstrated stable unplanned hospital contacts (27.0-31.1%), declining 30-day readmissions (11.0% to 7.0%), and high 30-day survival (91.6-92.4%).
Synapse has enriched 10 related papers. Consider them for comparative context: